Parameter values for cost-effectiveness analysis.
收藏NIAID Data Ecosystem2026-03-09 收录
下载链接：
https://figshare.com/articles/dataset/_Parameter_values_for_cost_effectiveness_analysis_/1195093
下载链接
链接失效反馈官方服务：
资源简介：
aRisk per unprotected receptive anal sex act, with no ART use by the infected partner, and no PrEP use.
bDrug costs: $9,312; physician visits: $300; renal function tests: $13; HIV tests: $23.
cAnnual cost of HIV care: $24,563; life expectancy 35 years.
dCost per case of GC/CT/syphilis treated: $79/30/709; relative proportion of GC/CT/syphilis: 0.453/0.353/0.194.
eDisability weights for asymptomatic HIV/symptomatic HIV/AIDS: 0.94/0.82/0.7; years lived per stage of HIV infection: asymptomatic: 7, symptomatic: 21, AIDS: 7.
fDisability weight for symptomatic GC or CT/GC or CT epididymitis: 0.933/0.833; prevalence of symptomatic GC/CT: 0.31/0.28; prevalence of GC/CT epididymitis: 0.0069/0.0093; disability weights for primary/secondary/tertiary syphilis: 0.985/0.952/0.717; prevalence of primary or secondary syphilis/tertiary syphilis: 0.61/0.009; years disability with tertiary syphilis: 5.
Abbreviations: GC: Gonorrhea; CT: chlamydia trachomatis; QALY: quality-adjusted life-year.
Parameter values for cost-effectiveness analysis.
创建时间：
2014-10-06
